aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Proteopure Inc. offers advanced protein isolation solutions designed for biomarker and pharmacokinetics research. The company's innovative technology focuses on efficient protein binding and isolation, catering primarily to the research and pharmaceutical sectors in the United States.
Proteopure has made significant strides in enhancing the accuracy and efficiency of protein research, impacting both academic and commercial research fields. Their solutions have been adopted by leading institutions, contributing to advancements in biomarker discovery and drug development.
Operating Status
Acquired
Ownership Type(s)
Private
Main Product(s)
Protein Isolation
Technology
Biotech
Tags
SaaS
Model Types
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Proteopure founded?
Proteopure was founded in 2005.
Where is Proteopure's headquarters located?
Proteopure's headquarters is located in Pittsburgh, PA, US.
When was Proteopure's last funding round?
Proteopure's most recent funding round was for $100k (USD) in March 2006.
How many employees does Proteopure have?
Proteopure has 5 employees as of Feb 5, 2024.
How much has Proteopure raised to-date?
As of July 05, 2023, Proteopure has raised a total of $100k (USD) since Mar 21, 2006.
Add Comparison
Total Raised to Date
$100k
USD
Last Update Mar 21, 2006
Last Deal Details
$100k
USD
Mar 21, 2006
Pre Seed
Total Employees Over Time
5
As of Feb 2024
Proteopure Address
2403 Sidney St
suite 255
Pittsburgh,
Pennsylvania
15203
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts